Market Research Logo

Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review

Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sting pathway activators; and B-select monoclonal antibodies to create immunotherapies for the treatment of cancers, infectious and autoimmune diseases. Its products under development are intended for the treatment of multiple indications, including pancreatic, lung, ovarian, prostate cancers, mesothelioma and glioblastoma. The company collaborates with various pharmaceutical companies to expand its products and technology platforms. Aduro BioTech is headquartered in Berkeley, California, the US.

Aduro BioTech Inc Key Recent Developments

Oct 31,2017: Aduro Biotech Reports Third Quarter 2017 Financial Results
Oct 09,2017: Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting
Aug 02,2017: Aduro Biotech Reports Second Quarter 2017 Financial Results
Jul 27,2017: Aduro Biotech Announces Andrea van Elsas, Ph.D., to be Named Chief Scientific Officer Effective September 1, 2017
May 02,2017: Aduro Biotech Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 6
Aduro BioTech Inc - Key Facts 6
Aduro BioTech Inc - Key Employees 7
Aduro BioTech Inc - Major Products and Services 8
Aduro BioTech Inc - History 9
Aduro BioTech Inc - Company Statement 11
Aduro BioTech Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Aduro BioTech Inc - Business Description 14
R&D Overview 14
Aduro BioTech Inc - Corporate Strategy 15
Aduro BioTech Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Aduro BioTech Inc - Strengths 16
Aduro BioTech Inc - Weaknesses 17
Aduro BioTech Inc - Opportunities 18
Aduro BioTech Inc - Threats 19
Aduro BioTech Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Aduro BioTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Aduro BioTech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Aduro BioTech Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Oct 31, 2017: Aduro Biotech Reports Third Quarter 2017 Financial Results 30
Oct 09, 2017: Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting 31
Aug 02, 2017: Aduro Biotech Reports Second Quarter 2017 Financial Results 32
Jul 27, 2017: Aduro Biotech Announces Andrea van Elsas, Ph.D., to be Named Chief Scientific Officer Effective September 1, 2017 33
May 02, 2017: Aduro Biotech Reports First Quarter 2017 Financial Results 34
Apr 20, 2017: Aduro Biotech Announces Management Promotions 35
Mar 02, 2017: Aduro Biotech Announces Upcoming Data Presentations at the Keystone Symposia on Cancer Immunology and Immunotherapy Conference 36
Mar 01, 2017: Aduro Biotech Announces Fourth Quarter and Full Year 2016 Financial Results 37
Jan 26, 2017: Aduro Biotech Announces Appointment of Leading Immunotherapy and Oncology Experts to Scientific Advisory Board 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
Aduro BioTech Inc, Key Facts 6
Aduro BioTech Inc, Key Employees 7
Aduro BioTech Inc, Major Products and Services 8
Aduro BioTech Inc, History 9
Aduro BioTech Inc, Other Locations 13
Aduro BioTech Inc, Subsidiaries 13
Aduro BioTech Inc, Key Competitors 20
Aduro BioTech Inc, Ratios based on current share price 21
Aduro BioTech Inc, Annual Ratios 22
Aduro BioTech Inc, Annual Ratios (Cont...1) 23
Aduro BioTech Inc, Interim Ratios 25
Aduro BioTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Aduro BioTech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Aduro BioTech Inc, Recent Deals Summary 29
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43
List of Figures
Aduro BioTech Inc, Performance Chart (2012 - 2016) 24
Aduro BioTech Inc, Ratio Charts 26
Aduro BioTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Aduro BioTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report